Yuanxin Xu
Overview
Explore the profile of Yuanxin Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
1059
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Szili-Torok T, Xu Y, de Borst M, Bakker S, Tietge U
J Am Heart Assoc
. 2023 Aug;
12(16):e028372.
PMID: 37581393
No abstract available.
12.
Wang Y, Zhou W, Liu D, Zhang Z, Xu Y, Wan X, et al.
Minerva Endocrinol (Torino)
. 2023 Aug;
48(4):440-446.
PMID: 37534872
Background: We aimed to determine the cis-expression Quantitative Trait Loci (cis-eQTL) and trans-eQTL of differentially expressed genes (DEGs) in insulin resistance (IR) related pathways. Methods: The expression profile data for...
13.
Pan L, Mora J, Walravens K, Wagner L, Hopper S, Loo L, et al.
Bioanalysis
. 2023 Aug;
15(14):773-814.
PMID: 37526071
The 2022 16th Workshop on Recent Issues in Bioanalysis (WRIB) took place in Atlanta, GA, USA on September 26-30, 2022. Over 1000 professionals representing pharma/biotech companies, CROs, and multiple regulatory...
14.
Abdelhady A, Phillips J, Xu Y, Stroh M
Clin Pharmacol Ther
. 2023 Jul;
114(3):591-603.
PMID: 37429825
Genome editing holds the potential for curative treatments of human disease, however, clinical realization has proven to be a challenging journey with incremental progress made up until recently. Over the...
15.
Liao H, Xu Y, Meng Q, Mao Z, Qiao Y, Liu Y, et al.
Cancer
. 2023 May;
129(19):2986-2998.
PMID: 37254628
Background: Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia (AML) characterized by its rapidly progressive and fatal clinical course if untreated, although it is curable if treated...
16.
Ren X, Du H, Cheng W, Wang Y, Xu Y, Yan S, et al.
Front Endocrinol (Lausanne)
. 2022 Nov;
13:997873.
PMID: 36407322
Background: Thyroid cancer is the most common malignant tumor of the endocrine system. Most patients with thyroid cancer have a good prognosis, although a small proportion experience recurrence and metastasis...
17.
Henry S, Arfvidsson C, Arrington J, Canadi J, Crowe D, Gupta S, et al.
Nucleic Acid Ther
. 2022 Sep;
32(5):369-377.
PMID: 36178478
Therapeutic oligonucleotides (ONs) have characteristics of both small molecules and biologics. Although safety assessment of ONs largely follows guidelines established for small molecules, the unique characteristics of ONs often require...
18.
Loo L, Harris S, Milton M, Meena , Lembke W, Berisha F, et al.
Bioanalysis
. 2022 May;
14(11):737-793.
PMID: 35578991
The 15th edition of the Workshop on Recent Issues in Bioanalysis (15th WRIB) was held on 27 September to 1 October 2021. Even with a last-minute move from in-person to...
19.
Cui J, Xu Y, Tu H, Zhao H, Wang H, Di L, et al.
Acta Pharm Sin B
. 2022 May;
12(3):1100-1125.
PMID: 35530155
Due to the special physiological and pathological characteristics of gliomas, most therapeutic drugs are prevented from entering the brain. To improve the poor prognosis of existing therapies, researchers have been...
20.
Shen Y, Pan X, Xu Y, Li Y, Ren X
J Acoust Soc Am
. 2022 Apr;
151(4):2613.
PMID: 35461480
Geoacoustic inversion using moving sensors attracts lots of interest due to the ease of deployment and low cost. However, the well-established techniques, such as matched-field inversion (MFI), may run into...